RadNet, Inc. (RDNT)
USD 53.37
(0.7%)
USD 53.37
(0.7%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.14 Billion USD | -17.11% |
| 2022 | 1.38 Billion USD | 9.69% |
| 2021 | 1.26 Billion USD | 16.65% |
| 2020 | 1.08 Billion USD | -5.08% |
| 2019 | 1.14 Billion USD | 72.37% |
| 2018 | 661.89 Million USD | 18.66% |
| 2017 | 557.8 Million USD | -9.75% |
| 2016 | 618.09 Million USD | -3.47% |
| 2015 | 640.28 Million USD | 7.2% |
| 2014 | 597.3 Million USD | 4.2% |
| 2013 | 573.21 Million USD | -1.52% |
| 2012 | 582.04 Million USD | 4.61% |
| 2011 | 556.37 Million USD | 10.4% |
| 2010 | 503.94 Million USD | 14.22% |
| 2009 | 441.22 Million USD | -10.05% |
| 2008 | 490.51 Million USD | 16.3% |
| 2007 | 421.78 Million USD | 131.86% |
| 2006 | 181.91 Million USD | 19.21% |
| 2005 | 152.59 Million USD | -9.86% |
| 2004 | 169.28 Million USD | 2.15% |
| 2003 | 165.71 Million USD | 4.52% |
| 2002 | 158.55 Million USD | 7.53% |
| 2001 | 147.45 Million USD | 10.64% |
| 2000 | 133.27 Million USD | 11.81% |
| 1999 | 119.2 Million USD | 13.16% |
| 1998 | 105.34 Million USD | 8.18% |
| 1997 | 97.37 Million USD | -14.41% |
| 1996 | 113.76 Million USD | 67.98% |
| 1995 | 67.72 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 996.15 Million USD | -13.27% |
| 2024 Q2 | 976.56 Million USD | -1.97% |
| 2023 Q1 | 1.45 Billion USD | 5.34% |
| 2023 FY | 1.14 Billion USD | -17.11% |
| 2023 Q4 | 1.14 Billion USD | -3.95% |
| 2023 Q2 | 1.19 Billion USD | -18.06% |
| 2023 Q3 | 1.19 Billion USD | -0.02% |
| 2022 Q4 | 1.38 Billion USD | 3.14% |
| 2022 FY | 1.38 Billion USD | 9.69% |
| 2022 Q3 | 1.34 Billion USD | -0.18% |
| 2022 Q2 | 1.34 Billion USD | 0.68% |
| 2022 Q1 | 1.33 Billion USD | 5.82% |
| 2021 FY | 1.26 Billion USD | 16.65% |
| 2021 Q4 | 1.26 Billion USD | 2.7% |
| 2021 Q3 | 1.22 Billion USD | -2.23% |
| 2021 Q1 | 1.18 Billion USD | 9.76% |
| 2021 Q2 | 1.25 Billion USD | 5.84% |
| 2020 Q2 | 1.08 Billion USD | -5.2% |
| 2020 FY | 1.08 Billion USD | -5.08% |
| 2020 Q1 | 1.14 Billion USD | 0.44% |
| 2020 Q4 | 1.08 Billion USD | 0.57% |
| 2020 Q3 | 1.07 Billion USD | -0.88% |
| 2019 Q1 | 1.1 Billion USD | 66.92% |
| 2019 FY | 1.14 Billion USD | 72.37% |
| 2019 Q2 | 1.16 Billion USD | 5.04% |
| 2019 Q3 | 1.15 Billion USD | -0.64% |
| 2019 Q4 | 1.14 Billion USD | -1.05% |
| 2018 Q4 | 661.89 Million USD | 18.38% |
| 2018 FY | 661.89 Million USD | 18.66% |
| 2018 Q1 | 568.93 Million USD | 2.0% |
| 2018 Q2 | 578.64 Million USD | 1.71% |
| 2018 Q3 | 559.11 Million USD | -3.37% |
| 2017 FY | 557.8 Million USD | -9.75% |
| 2017 Q4 | 557.8 Million USD | -8.48% |
| 2017 Q3 | 609.47 Million USD | -1.1% |
| 2017 Q2 | 616.26 Million USD | -1.8% |
| 2017 Q1 | 627.55 Million USD | 1.53% |
| 2016 Q3 | 648.03 Million USD | 1.8% |
| 2016 Q4 | 618.09 Million USD | -4.62% |
| 2016 Q2 | 636.57 Million USD | -1.68% |
| 2016 Q1 | 647.47 Million USD | 1.12% |
| 2016 FY | 618.09 Million USD | -3.47% |
| 2015 Q1 | 600.35 Million USD | 0.51% |
| 2015 Q2 | 641.33 Million USD | 6.82% |
| 2015 Q4 | 640.28 Million USD | 4.92% |
| 2015 FY | 640.28 Million USD | 7.2% |
| 2015 Q3 | 610.26 Million USD | -4.84% |
| 2014 Q3 | 613.58 Million USD | 0.31% |
| 2014 FY | 597.3 Million USD | 4.2% |
| 2014 Q4 | 597.3 Million USD | -2.65% |
| 2014 Q2 | 611.68 Million USD | -2.06% |
| 2014 Q1 | 624.54 Million USD | 8.96% |
| 2013 Q2 | 583.49 Million USD | -0.01% |
| 2013 Q4 | 573.21 Million USD | -1.89% |
| 2013 FY | 573.21 Million USD | -1.52% |
| 2013 Q1 | 583.58 Million USD | 0.26% |
| 2013 Q3 | 584.23 Million USD | 0.13% |
| 2012 FY | 582.04 Million USD | 4.61% |
| 2012 Q3 | 550.88 Million USD | -0.51% |
| 2012 Q2 | 553.69 Million USD | -0.31% |
| 2012 Q1 | 555.4 Million USD | -0.17% |
| 2012 Q4 | 582.04 Million USD | 5.66% |
| 2011 Q1 | 513.8 Million USD | 1.96% |
| 2011 Q3 | 523.68 Million USD | 0.49% |
| 2011 FY | 556.37 Million USD | 10.4% |
| 2011 Q4 | 556.37 Million USD | 6.24% |
| 2011 Q2 | 521.12 Million USD | 1.43% |
| 2010 Q2 | 489.94 Million USD | 4.29% |
| 2010 Q3 | 481.05 Million USD | -1.81% |
| 2010 FY | 503.94 Million USD | 14.22% |
| 2010 Q4 | 503.94 Million USD | 4.76% |
| 2010 Q1 | 469.78 Million USD | 6.47% |
| 2009 Q3 | 456.09 Million USD | -8.92% |
| 2009 Q4 | 441.22 Million USD | -3.26% |
| 2009 Q1 | 509.93 Million USD | 3.96% |
| 2009 Q2 | 500.78 Million USD | -1.79% |
| 2009 FY | 441.22 Million USD | -10.05% |
| 2008 Q2 | 503.98 Million USD | 0.09% |
| 2008 FY | 490.51 Million USD | 16.3% |
| 2008 Q3 | 505.53 Million USD | 0.31% |
| 2008 Q4 | 490.51 Million USD | -2.97% |
| 2008 Q1 | 503.54 Million USD | 19.38% |
| 2007 Q2 | 384.27 Million USD | 0.94% |
| 2007 Q1 | 380.69 Million USD | 0.0% |
| 2007 Q3 | 440.87 Million USD | 14.73% |
| 2007 Q4 | 421.78 Million USD | -4.33% |
| 2007 FY | 421.78 Million USD | 131.86% |
| 2006 Q3 | 181.91 Million USD | 4.29% |
| 2006 FY | 181.91 Million USD | 19.21% |
| 2006 Q2 | 174.43 Million USD | 2.92% |
| 2006 Q1 | 169.47 Million USD | 4.48% |
| 2005 Q3 | 152.59 Million USD | -8.25% |
| 2005 FY | 152.59 Million USD | -9.86% |
| 2005 Q4 | 162.21 Million USD | 6.3% |
| 2005 Q2 | 166.31 Million USD | -2.46% |
| 2005 Q1 | 170.5 Million USD | 0.88% |
| 2004 Q4 | 169.01 Million USD | -0.16% |
| 2004 Q1 | 169.9 Million USD | -1.18% |
| 2004 Q3 | 169.28 Million USD | 0.56% |
| 2004 Q2 | 168.33 Million USD | -0.92% |
| 2004 FY | 169.28 Million USD | 2.15% |
| 2003 Q2 | 170.04 Million USD | -3.37% |
| 2003 FY | 165.71 Million USD | 4.52% |
| 2003 Q3 | 165.71 Million USD | -2.55% |
| 2003 Q1 | 175.97 Million USD | -1.85% |
| 2003 Q4 | 171.93 Million USD | 3.75% |
| 2002 FY | 158.55 Million USD | 7.53% |
| 2002 Q4 | 179.28 Million USD | 13.08% |
| 2002 Q3 | 158.55 Million USD | -7.31% |
| 2002 Q2 | 171.06 Million USD | 2.75% |
| 2002 Q1 | 166.49 Million USD | 5.33% |
| 2001 Q1 | 124.64 Million USD | -1.63% |
| 2001 FY | 147.45 Million USD | 10.64% |
| 2001 Q4 | 158.06 Million USD | 7.2% |
| 2001 Q3 | 147.45 Million USD | 11.25% |
| 2001 Q2 | 132.53 Million USD | 6.33% |
| 2000 Q1 | 123.06 Million USD | 2.13% |
| 2000 Q4 | 126.71 Million USD | -4.92% |
| 2000 Q3 | 133.27 Million USD | 0.76% |
| 2000 Q2 | 132.26 Million USD | 7.48% |
| 2000 FY | 133.27 Million USD | 11.81% |
| 1999 Q1 | 79.8 Million USD | -1.85% |
| 1999 Q4 | 120.5 Million USD | 3.17% |
| 1999 FY | 119.2 Million USD | 13.16% |
| 1999 Q3 | 116.8 Million USD | 48.41% |
| 1999 Q2 | 78.7 Million USD | -1.38% |
| 1998 FY | 105.34 Million USD | 8.18% |
| 1998 Q3 | 77.8 Million USD | 7.46% |
| 1998 Q2 | 72.4 Million USD | 1.26% |
| 1998 Q1 | 71.5 Million USD | -1.65% |
| 1998 Q4 | 81.3 Million USD | 4.5% |
| 1997 Q1 | 79.3 Million USD | -7.68% |
| 1997 FY | 97.37 Million USD | -14.41% |
| 1997 Q4 | 72.7 Million USD | -3.07% |
| 1997 Q2 | 77.7 Million USD | -2.02% |
| 1997 Q3 | 75 Million USD | -3.47% |
| 1996 Q4 | 85.9 Million USD | 2.02% |
| 1996 Q3 | 84.2 Million USD | 20.29% |
| 1996 FY | 113.76 Million USD | 67.98% |
| 1996 Q2 | 70 Million USD | 0.43% |
| 1996 Q1 | 69.7 Million USD | 0.0% |
| 1995 FY | 67.72 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -39.45 Million USD | 3011.259% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | 19520.734% |
| Aspira Women's Health Inc. | -331 Thousand USD | 347093.958% |
| Biodesix, Inc. | 34.3 Million USD | -3247.859% |
| BioNexus Gene Lab Corp. | -5.79 Million USD | 19916.454% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | 92506.578% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | 92506.578% |
| Bionano Genomics, Inc. | 34.88 Million USD | -3192.672% |
| CareDx, Inc | -47.97 Million USD | 2494.01% |
| Check-Cap Ltd. | -24.75 Million USD | 4739.481% |
| Castle Biosciences, Inc. | -83.53 Million USD | 1474.999% |
| DarioHealth Corp. | -7.54 Million USD | 15316.614% |
| Exact Sciences Corporation | 1.94 Billion USD | 41.08% |
| Fulgent Genetics, Inc. | -82.56 Million USD | 1491.069% |
| Guardant Health, Inc. | 220.22 Million USD | -421.53% |
| ICON Public Limited Company | 3.56 Billion USD | 67.739% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | -132.524% |
| Illumina, Inc. | 1.21 Billion USD | 5.391% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | 21241.585% |
| iSpecimen Inc. | -2.14 Million USD | 53585.063% |
| Standard BioTools Inc. | 46.5 Million USD | -2369.681% |
| MDxHealth SA | 18.88 Million USD | -5981.811% |
| 23andMe Holding Co. | -141.37 Million USD | 912.431% |
| Medpace Holdings, Inc. | -103.32 Million USD | 1211.568% |
| Myriad Genetics, Inc. | 88.1 Million USD | -1203.689% |
| Mainz Biomed B.V. | 349.85 Thousand USD | -328193.15% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | 47181.292% |
| NeoGenomics, Inc. | 269.19 Million USD | -326.667% |
| Neogen Corporation | 735.62 Million USD | -56.132% |
| Inotiv, Inc. | 382.14 Million USD | -200.55% |
| Natera, Inc. | -200.1 Million USD | 673.982% |
| OpGen, Inc. | 11.89 Million USD | -9558.269% |
| OPKO Health, Inc. | 230.68 Million USD | -397.891% |
| Psychemedics Corporation | 334 Thousand USD | -343777.246% |
| Prenetics Global Limited | -43.33 Million USD | 2750.272% |
| Prenetics Global Limited | -43.33 Million USD | 2750.272% |
| Precipio, Inc. | -386 Thousand USD | 297651.813% |
| Personalis, Inc. | -8.02 Million USD | 14417.502% |
| Sera Prognostics, Inc. | -2.02 Million USD | 56902.671% |
| Sotera Health Company | 2.02 Billion USD | 43.293% |
| Neuronetics, Inc. | 2.79 Million USD | -40963.64% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 7588.753% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 7588.753% |
| Trinity Biotech plc | 63.73 Million USD | -1702.043% |
| T2 Biosystems, Inc. | 33.8 Million USD | -3297.172% |
| Twist Bioscience Corporation | -192.4 Million USD | 696.956% |
| Exagen Inc. | -12.77 Million USD | 9092.718% |